Intermittent Preventive Treatment in Infant in Mali
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
Studies have shown that Intermittent preventive treatment in infants (IPTi) with
Sulfadoxine-pyrimethamine (SP)reduced the incidence of clinical malaria and anemia without
modifying infants' serological response to EPI vaccines. Thus IPTi was seen as a potential
public health tool of great benefit to the children of Africa and a logical addition to the
Immunization Plus package. The objectives of this operational researcher were
- to develop an implementation model for IPTi in the health care system in Mali
- to assess its impact on the EPI vaccines and other health interventions coverage
- and on molecular makers of resistance to SP
Phase:
N/A
Details
Lead Sponsor:
University of Bamako
Collaborator:
UNICEF
Treatments:
Fanasil, pyrimethamine drug combination Pyrimethamine Sulfadoxine